Previous 10 | Next 10 |
Image source: The Motley Fool. Sophia Genetics SA (NASDAQ: SOPH) Q4 2021 Earnings Call Mar 15, 2022 , 8:30 a.m. ET Operator Continue reading For further details see: Sophia Genetics SA (SOPH) Q4 2021 Earnings Call Transcript
SOPHiA GENETICS SA (SOPH) Q4 2021 Earnings Conference Call March 15, 2022 08:30 A.M. ET Company Participants Jennifer Pottage - Head of IR Jurgi Camblong - Founder and CEO Ross Muken - CFO Peter Casasanto - Chief BioPharma Officer Conference Call Participants Tejas Savant - Morgan Stanley Mar...
SOPHiA Genetics press release (NASDAQ:SOPH): Q4 Non-GAAP EPS of -$0.28. Revenue of $10.94M (+39.7% Y/Y) misses by $0.26M. Outlook 2022: The company expects full year revenue for 2022 to be in the range of $51.5 million to $54 million, representing growth of 27% to 33% over full year revenue f...
Revenues Grew 40% for the Fourth Quarter and 42% for Full Year 2021 2022 Guidance Reaffirmed BOSTON and LAUSANNE, Switzerland, March 15, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, today reported financial results for the fourt...
SOPHia Genetics (NASDAQ:SOPH) will work with REALM IDx to develop next-generation sequencing ("NGS") research for cancer care and expand data sources for precision medicine. The companies say the purpose of their collaboration is "to enrich and scale the analysis of NGS assays, including...
SOPHiA GENETICS and REALM IDx Sign Letter of Intent to Collaborate in Accelerating Cancer Research Canada NewsWire The intended collaboration aims to help improve patient care by enhancing next-generation sequencing research for cancer care and expanding data sources f...
SOPHiA GENETICS HRD Solution Adopted in Asia Pacific Canada NewsWire BOSTON , LAUSANNE, Switzerland and TAIPEI CITY, Taiwan , March 9, 2022 /CNW/ -- SOPHiA GENETICS (Nasdaq: SOPH) today announced that SOFIVA GENOMICS, which is one of the largest ...
BOSTON and LAUSANNE, Switzerland, March 04, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, announced today Chief Executive Officer and Co-Founder Dr. Jurgi Camblong will participate in a fireside chat at the Barclays Global Healthcare Conferenc...
SOPHiA GENETICS Launches New Deep Learning Capabilities to Support the Detection of Homologous Recombination Deficiencies Canada NewsWire The SOPHiA DDM HRD Solution offers cost-effective, accurate, reliable, timely, and easily implementable in-house results to empower...
First Japanese Institution to Utilize SOPHiA GENETICS' Myeloid Plus Solution Canada NewsWire BOSTON , LAUSANNE, Switzerland , and HIROSHIMA, Japan , Feb. 22, 2022 /CNW/ -- SOPHiA GENETICS (Nasdaq: SOPH), today announced an agreement with Hiroshima Uni...
News, Short Squeeze, Breakout and More Instantly...
SOPHiA GENETICS Announces L'hôpital Universitaire Avicenne is Live on SOPHiA DDM™ Canada NewsWire The hospital will use the SOPHiA DDM™ Platform to enhance its testing and research of blood cancers BOSTON and ROLLE, Switzerland , July 2...
SOPHIA GENETICS Announces Expanded Relationship with Canada-Based OncoHelix PR Newswire OncoHelix is the first laboratory in Canada to adopt MSK-ACCESS® powered with SOPHiA DDM™ BOSTON and ROLLE, Switzerland , July 24 , 2024 /PRN...
SOPHiA GENETICS Announces Expanded Relationship with Canada-Based OncoHelix PR Newswire OncoHelix is the first laboratory in Canada to adopt MSK-ACCESS ® powered with SOPHiA DDM™ BOSTON and ROLLE, Switzerland , July 24, 2024 /...